Home
>
US Stocks
>
Ikena Oncology Inc
Ikena Oncology Inc
IKNA

Ikena Oncology Inc (IKNA)

$10.777.16%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
$10.24
Today Low/High
$10.24 / $11.08
52 Week Low/High
$9.63 / $37.61
Market Cap
$409.15M

Company Details

Ikena Oncology is a targeted oncology company focused on developing cancer therapies targeting key signaling pathways that drive the formation and spread of cancer. Ikena is advancing five programs that include four product candidates in either clinical development or IND-enabling studies: IK-930, a TEAD inhibitor targeting the Hippo signaling pathway; an ERK5 inhibitor program targeting the KRAS signaling pathway; IK-175, an AHR antagonist; IK-412, a kynurenine-degrading enzyme; and IK-007, an EP4 receptor antagonist. Ikena has entered into a global strategic collaboration with Bristol-Myers Squibb Company for its IK-175 and IK-412 programs.
Organisation
Ikena Oncology Inc
Employees
33

Discover more

Frequently Asked Questions

What is Ikena Oncology Inc (IKNA) share price today?

Can Indians buy Ikena Oncology Inc (IKNA) shares?

How can I buy Ikena Oncology Inc (IKNA) shares from India?

Can Fractional shares of Ikena Oncology Inc (IKNA) be purchased?

What are the documents required to start investing in Ikena Oncology Inc (IKNA) stocks?

We are a SEBI registered investement advisor